Financials DIVA Laboratories, Ltd.

Equities

4153

TW0004153002

Electronic Equipment & Parts

End-of-day quote Taipei Exchange 06:00:00 2024-05-14 pm EDT 5-day change 1st Jan Change
38.45 TWD 0.00% Intraday chart for DIVA Laboratories, Ltd. -1.28% +4.48%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,310 2,128 1,455 1,572 2,379 2,159
Enterprise Value (EV) 1 1,698 1,568 1,128 1,273 2,033 1,630
P/E ratio 43.3 x 38 x 95.4 x 72.4 x 48.3 x 29.4 x
Yield 4.74% - 1.05% 1.38% 2.47% 3.4%
Capitalization / Revenue 3.55 x 2.97 x 1.97 x 2.21 x 2.51 x 2.42 x
EV / Revenue 2.61 x 2.19 x 1.53 x 1.79 x 2.14 x 1.82 x
EV / EBITDA 29.2 x 19.4 x 13.1 x 37.4 x 21.8 x 16.2 x
EV / FCF 20.8 x 31.6 x -23.5 x -47.2 x 51.9 x 6.92 x
FCF Yield 4.81% 3.16% -4.25% -2.12% 1.93% 14.5%
Price to Book 1.9 x 1.88 x 1.47 x 1.59 x 2.34 x 2.09 x
Nbr of stocks (in thousands) 61,759 60,091 58,668 58,668 58,668 58,668
Reference price 2 37.40 35.42 24.80 26.80 40.55 36.80
Announcement Date 4/1/19 3/31/20 3/31/21 3/28/22 3/29/23 3/20/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 650.1 716.2 736.9 712.2 949.2 893.8
EBITDA 1 58.15 80.8 86.03 34.04 93.06 100.3
EBIT 1 44.91 65.36 70.54 22.6 84.83 92.15
Operating Margin 6.91% 9.13% 9.57% 3.17% 8.94% 10.31%
Earnings before Tax (EBT) 1 59.31 65.45 27.56 28.47 67.64 87.77
Net income 1 52.15 56.04 17.42 21.86 49.66 73.62
Net margin 8.02% 7.83% 2.36% 3.07% 5.23% 8.24%
EPS 2 0.8631 0.9327 0.2600 0.3700 0.8400 1.250
Free Cash Flow 1 81.67 49.59 -47.93 -26.96 39.16 235.6
FCF margin 12.56% 6.92% -6.5% -3.79% 4.13% 26.36%
FCF Conversion (EBITDA) 140.44% 61.38% - - 42.08% 234.87%
FCF Conversion (Net income) 156.59% 88.49% - - 78.86% 320.07%
Dividend per Share 2 1.774 - 0.2600 0.3700 1.000 1.250
Announcement Date 4/1/19 3/31/20 3/31/21 3/28/22 3/29/23 3/20/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 611 561 327 299 346 529
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 81.7 49.6 -47.9 -27 39.2 236
ROE (net income / shareholders' equity) 5.24% 4.84% 1.64% 2.21% 4.96% 7.19%
ROA (Net income/ Total Assets) 2.35% 3.11% 3.65% 1.23% 4.36% 4.62%
Assets 1 2,215 1,800 477 1,775 1,140 1,595
Book Value Per Share 2 19.70 18.90 16.90 16.80 17.30 17.60
Cash Flow per Share 2 10.20 8.430 5.520 5.100 5.900 9.150
Capex 1 21.7 9.26 20.8 12.1 10.3 7.49
Capex / Sales 3.34% 1.29% 2.82% 1.7% 1.09% 0.84%
Announcement Date 4/1/19 3/31/20 3/31/21 3/28/22 3/29/23 3/20/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 4153 Stock
  4. Financials DIVA Laboratories, Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW